TENSIXTEEN BIO Trademark

Trademark Overview

On Tuesday, October 19, 2021, a trademark application was filed for TENSIXTEEN BIO with the United States Patent and Trademark Office. The USPTO has given the TENSIXTEEN BIO trademark a serial number of 97081541. The federal status of this trademark filing is REGISTERED as of Tuesday, June 13, 2023. This trademark is owned by TENSIXTEEN BIO, INC.. The TENSIXTEEN BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceuticals research and development; scientific and medical research services in the field of pharmaceutical development; providing scientific research information in the field of pharmaceutical development; research and development of pharmaceuticals; research and development of technology in the field of pharmaceuticals; development of pharmaceutical preparations and medicines; drug development and discovery; research and development of therapeutic drugs for the prevention or treatment of human diseases; scientific research in the field of drug discovery and development for others; biomedical research services; scientific research; preclinical development of therapeutic product; research and development in the field of medical diagnostics; providing scientific information services in the field of medical diagnostics; scientific research in the field of medical diagnostics
tensixteen bio

General Information

Serial Number97081541
Word MarkTENSIXTEEN BIO
Filing DateTuesday, October 19, 2021
Status700 - REGISTERED
Status DateTuesday, June 13, 2023
Registration Number7081941
Registration DateTuesday, June 13, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2022

Trademark Statements

Disclaimer with Predetermined Text"BIO"
Goods and ServicesPharmaceuticals research and development; scientific and medical research services in the field of pharmaceutical development; providing scientific research information in the field of pharmaceutical development; research and development of pharmaceuticals; research and development of technology in the field of pharmaceuticals; development of pharmaceutical preparations and medicines; drug development and discovery; research and development of therapeutic drugs for the prevention or treatment of human diseases; scientific research in the field of drug discovery and development for others; biomedical research services; scientific research; preclinical development of therapeutic product; research and development in the field of medical diagnostics; providing scientific information services in the field of medical diagnostics; scientific research in the field of medical diagnostics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 5, 2021
Primary Code042
First Use Anywhere DateThursday, January 27, 2022
First Use In Commerce DateThursday, January 27, 2022

Trademark Owner History

Party NameTENSIXTEEN BIO, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameTENSIXTEEN BIO, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameTENSIXTEEN BIO, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94108

Trademark Events

Event DateEvent Description
Tuesday, June 13, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 13, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, May 10, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 9, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 8, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 18, 2023USE AMENDMENT FILED
Monday, May 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 18, 2023TEAS STATEMENT OF USE RECEIVED
Monday, April 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 17, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 1, 2022NON-FINAL ACTION E-MAILED
Thursday, September 1, 2022NON-FINAL ACTION WRITTEN
Thursday, September 1, 2022ASSIGNED TO EXAMINER
Thursday, September 1, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 23, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, August 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 27, 2022NON-FINAL ACTION E-MAILED
Wednesday, July 27, 2022NON-FINAL ACTION WRITTEN
Tuesday, July 26, 2022ASSIGNED TO EXAMINER
Monday, March 21, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, March 21, 2022ASSIGNED TO LIE
Thursday, March 17, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, November 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 22, 2021NEW APPLICATION ENTERED

Related Keywords

tensixteen development research field scientific medical pharmaceutical diagnostics services pharmaceuticals drug